Untangling the pharma patent puzzle

27-09-2017

Renata Campello Afonso

Untangling the pharma patent puzzle

luchschen / iStockphoto.com

It is too soon to say what impact the new rules for examining pharmaceutical patents in Brazil will have, but there are some early clues, says Renata Campello Afonso of Luiz Leonardos & Advogados.


Renata Campello Afonso, Luiz Leonardos & Advogados, ANVISA , pharmaceutical, patent, INPI, applications, Brazilian Public Healthcare System

WIPR